Found: 16
Select item for more details and to access through your institution.
A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. 325, doi. 10.1016/j.clgc.2021.02.001
- By:
- Publication type:
- Article
Prostate cancer–Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancer.
- Published in:
- Pilot & Feasibility Studies, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40814-022-01136-7
- By:
- Publication type:
- Article
Rectal spacers in patients with prostate cancer undergoing radiotherapy: A survey of UK uro‐oncologists.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 8, p. 1, doi. 10.1111/ijcp.14338
- By:
- Publication type:
- Article
A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis.
- Published in:
- Journal of International Medical Research, 2019, v. 47, n. 10, p. 4664, doi. 10.1177/0300060519863546
- By:
- Publication type:
- Article
Bench to Bedside Development of [ 18 F]Fluoromethyl-(1,2- 2 H 4)choline ([ 18 F]D4-FCH).
- Published in:
- Molecules, 2023, v. 28, n. 24, p. 8018, doi. 10.3390/molecules28248018
- By:
- Publication type:
- Article
Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?
- Published in:
- Cancer Medicine, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cam4.7327
- By:
- Publication type:
- Article
Is the digital rectal exam any good as a prostate cancer screening test?
- Published in:
- British Journal of General Practice, 2024, v. 74, n. 740, p. 137, doi. 10.3399/bjgp24x736677
- By:
- Publication type:
- Article
3′-Deoxy-3′-F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 6, p. 831, doi. 10.1007/s00259-015-3000-2
- By:
- Publication type:
- Article
Positron emission Tomography imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00044
- By:
- Publication type:
- Article
Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99</sup>mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 227, doi. 10.2967/jnumed.122.264296
- By:
- Publication type:
- Article
Biodistribution and Radiation Dosimetry of Deuterium- Substituted <sup>18</sup>F-Fluoromethyl-[1, 2-²H<sub>4</sub>]Choline in Healthy Volunteers.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 2, p. 256, doi. 10.2967/jnumed.113.129577
- By:
- Publication type:
- Article
<sup>18</sup>F-ICMT-11, a Caspase-3-Specific PET Tracer for Apoptosis: Biodistribution and Radiation Dosimetry.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 9, p. 1551, doi. 10.2967/jnumed.112.118760
- By:
- Publication type:
- Article
Cervical paraganglioma-A case report and review of all cases reported to the Manchester Children's Tumour Registry 1954-2004.
- Published in:
- Pediatric Blood & Cancer, 2007, v. 48, n. 1, p. 112, doi. 10.1002/pbc.20919
- By:
- Publication type:
- Article
Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab).
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1408667
- By:
- Publication type:
- Article
ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER.
- Published in:
- Acta Clinica Croatica, 2022, v. 61, p. 51, doi. 10.20471/acc.2022.61.s3.7
- By:
- Publication type:
- Article
[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 5, p. 1239, doi. 10.1007/s00259-019-04532-z
- By:
- Publication type:
- Article